-ISO 9001:2000


Telmisartan and Hydrochlorothiazide, Telmisartan 20, 40 and 80 tablets.


back to Speciality Products

- - -
Recharje Forte
Back to
Speciality Products

Telmikaa (Telmisartan) is a nonpeptide angiotensin II receptor (type AT1) antagonist. Telmisartan is insoluble in water and hence the rate of dissolution & its bioavailability is less. Therefore, formulating optimum bioavailable telmisartan is a challenge. Telmikaa is manufactured by Maxisorb Technology which significantly enhances the absorption of telmisartan, transforming it into optimum bioavailable formulation. Indian Patent Office has granted patent to Troikaa for Telimisartan Formulations as well as for the process.

Thus, Telmikaa 20, 40, 80 & Telmikaa H assures superior pharmacokinetic profile, as compared to the leading Indian brand. This has been established by appropriate pharmacokinetic studies. Needless to say, Telmikaa is bio-equivalent to the innovator brand.

Telmisartan 20/40/80mg & Telmisartan + HCTZ 12.5mg

That's why Telmikaa is not just another telmisartan, it is the only optimum bioavailable Telmisartan in India. Telmikaa promises superior outcome in B.P. management.

Indication: Telmikaa (telmisartan) is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Telmisartan & hydrochlorothiazide combination is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy.

1. Telmikaa is bioequivalent to innovator brand Micardis.
2. Telmikaa offers;

(i) More pronounced B.P. control.
(ii) Less need for higher dose.
(iii) Less need for combination therapy.

Presentation: Telmikaa 20, 40, 80 & H (Along with HCTZ)


Corporate Philosophy
Troikaa Pharmaceuticals Limited is a young pharmaceutical company, which has acquired a reputation of an innovative company, over the years. We have been steadfastly sowing the basics of Innovation, Quality and Service to reap excellence.

Home | Company | Products | Technologies | International Business | Media Coverage | Human Resources | Research Publications | Partnering

Copyright ę 2009 Troikaa Pharmaceuticals Ltd. - Disclaimer